Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE‐ENOX study
Open Access
- 14 December 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (2) , 227-229
- https://doi.org/10.1111/j.1538-7836.2004.01090.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorderBlood, 2004
- Inherited thrombophilia and poor pregnancy outcomeBest Practice & Research Clinical Obstetrics & Gynaecology, 2003
- Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophiliaJournal of Thrombosis and Haemostasis, 2003
- The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2002
- Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastageFertility and Sterility, 2002
- Enoxaparin Sodium Improves Pregnancy Outcome in Aspirin-resistant Antiphospholipid/Antiprotein Antibody SyndromesThrombosis and Haemostasis, 2002
- Gestational Outcome in Thrombophilic Women with Recurrent Pregnancy Loss Treated by EnoxaparinThrombosis and Haemostasis, 2000
- Factor V Leiden Mutation as a Risk Factor for Recurrent Pregnancy LossAnnals of Internal Medicine, 1998
- Increased fetal loss in women with heritable thrombophiliaThe Lancet, 1996